OmniCorder's BioScanIR shown effective in mapping perforated vessels
OmniCorder Technologies Inc. revealed this week that the company's BioScanIR System was the subject of a recent study published in the June issue of Physics in Medicine and Biology.
Researchers at the University of Geneva, Switzerland, examined the use of the company's Quantum Well Infrared Photodetector (QWIP) technology, used in OmniCorder's BioScanIR system, to map human skeletal muscle perforator vessels.
The study examined the limitations in other existing modalities such as near infrared spectroscopy (NIRS) and laser Doppler flowmetry (LDF), two commonly used techniques for non-invasive study of muscle metabolism and blood perfusion, and how QWIP technology can be implemented to overcome some of their limitations, such as spatial variability, which makes the data interpretation and comparison difficult.
In addition, the study reported that the accurate comparison of the metabolic activity of two different muscle regions is not possible without reliable maps of vascular 'singularities' such as the perforator vessels and that the BioScanIR system can more accurately and more quickly obtain this important information.
The BioScanIR system, which is available commercially in the U.S. and Europe, detects diseases that affect changes in blood perfusion by detecting minute changes in the pattern of infrared photon emissions over time. The detector technology used in the system, QWIP, was originally developed for the Department of Defense's Ballistic Missile Defense Initiative. OmniCorder owns an exclusive, worldwide license to use the technology for biomedical applications.
Researchers at the University of Geneva, Switzerland, examined the use of the company's Quantum Well Infrared Photodetector (QWIP) technology, used in OmniCorder's BioScanIR system, to map human skeletal muscle perforator vessels.
The study examined the limitations in other existing modalities such as near infrared spectroscopy (NIRS) and laser Doppler flowmetry (LDF), two commonly used techniques for non-invasive study of muscle metabolism and blood perfusion, and how QWIP technology can be implemented to overcome some of their limitations, such as spatial variability, which makes the data interpretation and comparison difficult.
In addition, the study reported that the accurate comparison of the metabolic activity of two different muscle regions is not possible without reliable maps of vascular 'singularities' such as the perforator vessels and that the BioScanIR system can more accurately and more quickly obtain this important information.
The BioScanIR system, which is available commercially in the U.S. and Europe, detects diseases that affect changes in blood perfusion by detecting minute changes in the pattern of infrared photon emissions over time. The detector technology used in the system, QWIP, was originally developed for the Department of Defense's Ballistic Missile Defense Initiative. OmniCorder owns an exclusive, worldwide license to use the technology for biomedical applications.